| Cytokines in clinical cancer immunotherapy P Berraondo, MF Sanmamed, MC Ochoa, I Etxeberria, MA Aznar, ... British journal of cancer 120 (1), 6-15, 2019 | 955 | 2019 |
| Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma KA Schalper, ME Rodriguez-Ruiz, R Diez-Valle, A López-Janeiro, ... Nature medicine 25 (3), 470-476, 2019 | 537 | 2019 |
| CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity Á Teijeira, S Garasa, M Gato, C Alfaro, I Migueliz, A Cirella, C de Andrea, ... Immunity 52 (5), 856-871. e8, 2020 | 475 | 2020 |
| Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs) C Alfaro, A Teijeira, C Oñate, G Perez, MF Sanmamed, MP Andueza, ... Clinical Cancer Research 22 (15), 3924-3936, 2016 | 366 | 2016 |
| Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy E Perez-Ruiz, L Minute, I Otano, M Alvarez, MC Ochoa, V Belsue, ... Nature 569 (7756), 428-432, 2019 | 360 | 2019 |
| Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells MC Ochoa, L Minute, I Rodriguez, S Garasa, E Perez‐Ruiz, S Inogés, ... Immunology and cell biology 95 (4), 347-355, 2017 | 215 | 2017 |
| An RNA toolbox for cancer immunotherapy F Pastor, P Berraondo, I Etxeberria, J Frederick, U Sahin, E Gilboa, ... Nature Reviews Drug Discovery 17 (10), 751-767, 2018 | 200 | 2018 |
| Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma I Tirapu, E Huarte, C Guiducci, A Arina, M Zaratiegui, O Murillo, ... Cancer research 66 (4), 2442-2450, 2006 | 184 | 2006 |
| Targeting NK-cell checkpoints for cancer immunotherapy A Muntasell, MC Ochoa, L Cordeiro, P Berraondo, ALD de Cerio, M Cabo, ... Current opinion in immunology 45, 73-81, 2017 | 182 | 2017 |
| Systemic messenger RNA as an etiological treatment for acute intermittent porphyria L Jiang, P Berraondo, D Jericó, LT Guey, A Sampedro, A Frassetto, ... Nature medicine 24 (12), 1899-1909, 2018 | 168 | 2018 |
| In vitro and in vivo comparative study of chimeric liver-specific promoters MG Kramer, M Barajas, N Razquin, P Berraondo, M Rodrigo, C Wu, ... Molecular therapy 7 (3), 375-385, 2003 | 164 | 2003 |
| Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration G Alvarez-Sola, I Uriarte, MU Latasa, MG Fernandez-Barrena, R Urtasun, ... Gut 66 (10), 1818-1828, 2017 | 144 | 2017 |
| Innate immune mediators in cancer: between defense and resistance P Berraondo, L Minute, D Ajona, L Corrales, I Melero, R Pio Immunological Reviews 274 (1), 290-306, 2016 | 144 | 2016 |
| Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system P Berraondo, C Nouzé, X Préville, D Ladant, C Leclerc Cancer research 67 (18), 8847-8855, 2007 | 141 | 2007 |
| Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells J Medina-Echeverz, J Fioravanti, M Zabala, N Ardaiz, J Prieto, ... The Journal of Immunology 186 (2), 807-815, 2011 | 128 | 2011 |
| IL8, neutrophils, and NETs in a collusion against cancer immunity and immunotherapy A Teijeira, S Garasa, MC Ochoa, M Villalba, I Olivera, A Cirella, ... Clinical Cancer Research 27 (9), 2383-2393, 2021 | 127 | 2021 |
| Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients ME Rodriguez-Ruiz, JL Perez-Gracia, I Rodriguez, C Alfaro, C Oñate, ... Annals of Oncology 29 (5), 1312-1319, 2018 | 118 | 2018 |
| Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders A Paneda, L Vanrell, I Mauleon, JS Crettaz, P Berraondo, EJ Timmermans, ... Human gene therapy 20 (8), 908-917, 2009 | 115 | 2009 |
| Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal … M Gonzalez-Aparicio, P Alzuguren, I Mauleon, J Medina-Echeverz, ... Gut 60 (3), 341-349, 2011 | 113 | 2011 |
| Intratumor adoptive transfer of IL-12 mRNA transiently engineered antitumor CD8+ T cells I Etxeberria, E Bolaños, JI Quetglas, A Gros, A Villanueva, J Palomero, ... Cancer Cell 36 (6), 613-629. e7, 2019 | 109 | 2019 |
Álvaro Teijeira SánchezCIMA, Universidad de NavarraDirección de correo verificada de unav.es
